MAP2K4 and diffuse large B-cell lymphoma: Furthermore, Li et al. discovered that LINC01857 could competitively bind to miR-141-3p to upregulate mitogen-activated protein kinase 4, thereby accelerating the EMT in diffuse large B-cell lymphoma [29].